Liminal Biosciences Inc (LMNL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 0 | 192 | 135 | 20 | 166 |
| Gross Profit | N/A | 192 | 135 | 20 | 166 |
| Operating Expenses | 7,319 | 3,978 | 11,434 | 10,179 | 14,524 |
| Operating Income | -7,319 | -3,786 | -11,299 | -10,159 | -14,358 |
| Interest Expense | 1,073 | 309 | 1,490 | 1,352 | 1,899 |
| Other Income | -596 | 2,374 | 5,072 | 1,255 | 89 |
| Pre-tax Income | -8,988 | -1,721 | -7,717 | -10,257 | -16,167 |
| Net Income Continuous | -8,988 | -113,670 | 95,427 | -1,546 | -16,167 |
| Net Income Discontinuous | 173 | 100,696 | -30,080 | -24,617 | -299 |
| Minority Interests | -446 | -63 | 66 | -76 | -461 |
| Net Income | $-8,369 | $-12,911 | $65,281 | $-26,087 | $-16,005 |
| EPS Basic Total Ops | -2.68 | -4.25 | 21.77 | -8.71 | -5.37 |
| EPS Basic Continuous Ops | -2.90 | -37.87 | 31.87 | -0.52 | -5.40 |
| EPS Basic Discontinuous Ops | 0.06 | 33.52 | -10.05 | -8.22 | -0.10 |
| EPS Diluted Total Ops | -2.68 | -4.25 | 21.77 | -8.71 | -5.37 |
| EPS Diluted Continuous Ops | -2.90 | -37.87 | 31.87 | -0.52 | -5.40 |
| EPS Diluted Discontinuous Ops | 0.06 | 33.52 | -10.05 | -8.22 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -2.80 | -2.30 | -2.60 | N/A | N/A |
| EBITDA(a) | $-7,092 | $-3,165 | $-10,717 | $-8,918 | $-13,336 |